Susquehanna International Group, LLP Gain Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.94 - $1.99 $9,400 - $19,900
10,000 New
10,000 $17,000
Q1 2024

May 07, 2024
BUY
$3.21 - $5.04 $53,286 - $83,664
16,600 New
16,600 $62,000
Q2 2023

Aug 11, 2023
BUY
$4.36 - $5.5 $58,424 - $73,700
13,400 New
13,400 $60,000

Others Institutions Holding GANX

# of Institutions
23
Shares Held
2.39M
Call Options Held
10K
Put Options Held
0
View Full List

About Gain Therapeutics, Inc.

GANX Quotes by TradingView
  • Ticker GANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,883,400
  • Market Cap $18.5M
  • Description
  • Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...
More about GANX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email